Close Menu

stock rating

An analyst at the investment firm said that the expanded production of Illumina's HiSeq sequencing platform is expected to result in sequential revenue growth in the first and second quarters of 2011, but revenue growth will likely abate in the third quarter.

The new revenue estimates come amid concerns about the effect of the Japanese earthquake, competition in the next-generation sequencing space, and government funding on the company's business.

The investment firm gave Fluidigm an "Outperform" rating and a valuation of between $17 and $18.

An Oppenheimer analyst noted the quality of Complete Genomics' data, a continued demand for sequencing service providers, and the progression of sequencing into clinical applications.

In a research note, analyst Quintin Lai noted the recent FDA approval of the protein biomarker-based test developer's Galectin-3 test, as well as partnerships forged with several IVD instrument manufacturers that could speed adoption of the test.

The eight firms for which Jefferies resumed coverage are Myriad Genetics, Cepheid, Gen-Probe, Complete Genomics, Exact Sciences, Genomic Health, Sequenom, and Nanosphere.

In addition to initiating coverage of Cepheid, Gen-Probe, Myriad Genetics, and Qiagen, the investment bank also began coverage of Alere and Hologic.

Despite the upgrade, an analyst expressed concern about the commercial value of the test, noting the cost involved.

Wedbush also placed a 12-month price target of $9 on Caliper's shares, saying that "new product traction in next-generation sequencing sample preparation as well as greater adoption of the company's products in molecular diagnostics can drive upside to consensus estimates."

The investment firm gave Illumina an "outperform" rating and an "aggressive growth" company profile.

Pages

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.